Genvigir, Fabiana D. V; Nishikawa, Alvaro Mitsunori; Felipe, Claudia R; Silva Junior, Helio Tedesco; Oliveira, Nagilla; Salazar, Antony B. C; Pestana, José O. Medina; Doi, Sonia Q; Hirata, Mario Hiroyuki 
; Hirata, Rosario Dominguez Crespo
Source: Pharmacotherapy. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana D. V et al. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients. Pharmacotherapy, v. 37, n. 5, p. 535-545, 2017Tradução . . Disponível em: https://doi.org/10.1002/phar.1928. Acesso em: 03 nov. 2024.APA
Genvigir, F. D. V., Nishikawa, A. M., Felipe, C. R., Silva Junior, H. T., Oliveira, N., Salazar, A. B. C., et al. (2017). Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients. Pharmacotherapy, 37( 5), 535-545. doi:10.1002/phar.1928NLM
Genvigir FDV, Nishikawa AM, Felipe CR, Silva Junior HT, Oliveira N, Salazar ABC, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients [Internet]. Pharmacotherapy. 2017 ; 37( 5): 535-545.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/phar.1928Vancouver
Genvigir FDV, Nishikawa AM, Felipe CR, Silva Junior HT, Oliveira N, Salazar ABC, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients [Internet]. Pharmacotherapy. 2017 ; 37( 5): 535-545.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/phar.1928
